HomeKAPA • NYSEAMERICAN
add
Kairos Pharma Ltd
Previous close
$0.70
Day range
$0.66 - $0.69
Year range
$0.40 - $4.00
Market cap
11.21M USD
Avg Volume
1.61M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.27M | 341.11% |
Net income | -1.26M | -290.71% |
Net profit margin | — | — |
Earnings per share | -0.08 | — |
EBITDA | -1.23M | -396.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.62M | 8,940.00% |
Total assets | 7.94M | 716.56% |
Total liabilities | 805.00K | -76.13% |
Total equity | 7.13M | — |
Shares outstanding | 16.85M | — |
Price to book | 1.54 | — |
Return on assets | -46.19% | — |
Return on capital | -53.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.26M | -290.71% |
Cash from operations | -714.00K | -2,083.33% |
Cash from investing | — | — |
Cash from financing | 3.06M | 3,535.96% |
Net change in cash | 2.34M | 4,522.64% |
Free cash flow | -399.25K | -352.49% |
About
Founded
2013
Headquarters
Website
Employees
3
